Department of Neurology and Laboratoire de Neurosciences Fonctionnelles et Pathologies, CHU Amiens-Picardie and Jules Verne University of Picardy, Amiens, France.
Alzheimer Dis Assoc Disord. 2022;36(4):359-361. doi: 10.1097/WAD.0000000000000520. Epub 2022 Jul 19.
Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have not been identified. Our objective was to examine baseline neuropsychological indicators that could discriminate between stable SCD Versus progression toward an NCD. We retrospectively included patients consulting for SCD at a university medical center's memory center (Amiens, France) who had undergone 3 or more neuropsychological assessments. Among the 80 patients with SCD, 11 had progressed to an NCD. The combination of age, memory, and speed scores at the baseline assessment predicted the progression of SCD with a sensitivity of 91%, and a negative predictive value of 98%. The present results constitute a first step (pending prospective studies) toward helping physicians to identify cases of SCD at risk of progression and, in particular, identifying patients with SCD who will not progress by examining baseline neuropsychological indicators. ClinicalTrials.gov ID: NCT04880252.
一些有主观认知下降(SCD)的患者会进展为神经认知障碍(NCD),而另一些则保持稳定;然而,这种进展的神经心理学决定因素尚未确定。我们的目的是研究基线神经心理学指标,以区分稳定的 SCD 与进展为 NCD。我们回顾性地纳入了在法国亚眠大学医学中心记忆中心就诊的 SCD 患者(n=80),这些患者接受了 3 次或更多次神经心理学评估。在 80 名 SCD 患者中,有 11 名进展为 NCD。基线评估时的年龄、记忆和速度评分的组合对 SCD 的进展具有较高的预测价值,敏感性为 91%,阴性预测值为 98%。这些结果是(等待前瞻性研究)帮助医生识别有进展风险的 SCD 病例的第一步,特别是通过检查基线神经心理学指标来识别不会进展的 SCD 患者。ClinicalTrials.gov ID:NCT04880252。